MREO Mereo BioPharma Group Plc
Biotechnology NasdaqCM
Trading Signals (MREO)
Overall Signal
SELL
Strong sellish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $1.4
- Medium Support $1.49
- Weak Support $1.59
Resistance Levels
- Weak Resistance $1.79
- Medium Resistance $1.89
- Strong Resistance $1.98
Stop Loss Suggestions
- Conservative $2.21
- Moderate $1.84
- Aggressive $1.94
Analyst Ratings
Current Rating
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | SELL |
|
Short & Medium Term |
| Oscillators | SELL |
|
Short Term |
| Trend Indicators | SELL |
|
Medium Term |
| Volume Indicators | SELL |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (MREO)
Quarterly Outlook :
2025-12-16
Bullish Scenario
from current 36.69%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (29.21) indicates a strong trend. -DI > +DI suggests strong bearish directional bias. RSI (37.30) is in bearish territory, indicating downward momentum. MACD line (-0.31) is below Signal line (-0.28) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 0.31, indicating the average weekly price range.
2025-12-16
Base Scenario
from current -18.34%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (29.21) indicates a strong trend. -DI > +DI suggests strong bearish directional bias. RSI (37.30) is in bearish territory, indicating downward momentum. MACD line (-0.31) is below Signal line (-0.28) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 0.31, indicating the average weekly price range.
2025-12-16
Bearish Scenario
from current -45.86%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (29.21) indicates a strong trend. -DI > +DI suggests strong bearish directional bias. RSI (37.30) is in bearish territory, indicating downward momentum. MACD line (-0.31) is below Signal line (-0.28) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 0.31, indicating the average weekly price range.
Annual Outlook
2025-12-16
Bullish Scenario
from current 73.37%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (29.21) indicates a strong trend. -DI > +DI suggests strong bearish directional bias. RSI (37.30) is in bearish territory, indicating downward momentum. MACD line (-0.31) is below Signal line (-0.28) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 0.31, indicating the average weekly price range.
2025-12-16
Base Scenario
from current -36.69%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (29.21) indicates a strong trend. -DI > +DI suggests strong bearish directional bias. RSI (37.30) is in bearish territory, indicating downward momentum. MACD line (-0.31) is below Signal line (-0.28) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 0.31, indicating the average weekly price range.
2025-12-16
Bearish Scenario
from current -91.72%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (29.21) indicates a strong trend. -DI > +DI suggests strong bearish directional bias. RSI (37.30) is in bearish territory, indicating downward momentum. MACD line (-0.31) is below Signal line (-0.28) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 0.31, indicating the average weekly price range.
Technical Analysis (MREO)
Trend Identification
EMA
Exponential Moving Average
Current price (1.69) is below both Short MA (1.97) and Long MA (2.34). This indicates strong bearish momentum. Short MA (1.97) is below Long MA (2.34), a bearish crossover ('Death Cross' if it's a significant period). This indicates a downward trend. MAs (1.97, 2.34, 2.34) show mixed alignment, suggesting market indecision or range-bound activity. Consider short positions. Use the MAs as dynamic resistance levels.
MACD
Moving Average Convergence Divergence
MACD line is crossing the Signal line. This is a crucial point, signaling a potential trend change. Monitor closely. Both MACD and Signal lines are below the zero line, reinforcing bearish momentum (bearish territory).
ADX
Average Directional Index
ADX (30.25) indicates a strong trend is present. -DI (31.54) is above +DI (17.73), suggesting a bearish directional bias. This combination points to a strong downward trend. Consider taking short positions, as the strong downward trend is confirmed.
Momentum Measurement
RSI (2025-12-16)
Relative Strength Index
RSI (34.09) is in the bearish territory, but not yet oversold. This indicates downward momentum. Monitor for continuation or signs of strength.
OBV (2025-12-16)
On-Balance Volume
OBV (-48997919.00) is falling, indicating selling pressure and distribution. Price is falling and OBV is falling. This is bearish confirmation, indicating selling pressure supports the price decrease. Consider holding short positions or initiating new ones. Volume is supporting the trend.
Stochastic (2025-12-16)
Stochastic Oscillator
Stochastics (%K: 8.55, %D: 17.05) are in the oversold zone (below 20). This suggests the asset may be losing downward momentum. A bearish crossover (%K below %D) is observed. This indicates downward momentum. Be cautious if it's already in the oversold region.
CCI (2025-12-16)
Commodity Channel Index
CCI (-73.21) is between -100 and 0. This indicates bearish momentum is present, but not yet extreme. A move below 0 from positive territory (bearish zero-line cross) can indicate a potential sell signal.
Volatility Measurement
ATR (2025-12-16)
Average True Range
Current ATR is 0.1500. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2025-12-16)
Volatility Bands
Current price (1.69) is within the Bollinger Bands (1.04 - 2.90). This suggests the price is trading within its typical volatility range. Price is below the Middle Band (1.97), indicating short-term bearish bias. Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility.
Risk Management & Potential Reversals (MREO)
SAR (2025-12-16)
Parabolic Stop and Reverse
SAR points above price indicate bearish trend. Current SAR at 2.21 is 30.77% from price. Consider SAR as a potential take-profit level or to confirm a downtrend.
Stochastic (2025-12-16)
Oversold
Stochastic is in oversold territory (8.6). Monitor for potential bullish crossover or movement above 20, which could signal a reversal. Current crossover status: Bearish.
RSI (2025-12-16)
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2025-12-16)
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is in the lower half of the bands, suggesting a bearish bias.No indication of imminent volatility expansion or reversal.
Holder List Top 20 (MREO)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Janus Henderson Group PLC | INSTITUTIONAL | 22735121 | 14.3% | 2025-03-31 |
| Rubric Capital Management LP | INSTITUTIONAL | 15307347 | 9.63% | 2025-03-31 |
| Mangrove Partners | INSTITUTIONAL | 8636485 | 5.43% | 2025-03-31 |
| Frazier Life Sciences Management, L.P. | INSTITUTIONAL | 7819863 | 4.92% | 2025-03-31 |
| Deerfield Management Company, L.P. (Series C) | INSTITUTIONAL | 6710429 | 4.22% | 2025-03-31 |
| Rock Springs Capital Management, LP | INSTITUTIONAL | 6684247 | 4.2% | 2025-03-31 |
| Alkeon Capital Management LLC | INSTITUTIONAL | 4698100 | 2.95% | 2025-03-31 |
| 683 Capital Management LLC | INSTITUTIONAL | 4635000 | 2.92% | 2025-03-31 |
| Clearline Capital, LP | INSTITUTIONAL | 3217894 | 2.02% | 2025-03-31 |
| Tejara Capital Ltd | INSTITUTIONAL | 2521324 | 1.59% | 2025-03-31 |
| abrdn World Healthcare Fund | MUTUALFUND | 1300359 | 0.82% | 2025-03-31 |
| abrdn Life Sciences Investors | MUTUALFUND | 812053 | 0.51% | 2025-03-31 |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | MUTUALFUND | 759100 | 0.48% | 2025-04-30 |
| Tema ETF Trust-Tema GLP-1, Obesity & Cardiometabolic ETF | MUTUALFUND | 267459 | 0.17% | 2025-02-28 |
| Tema ETF Trust-Tema Oncology ETF | MUTUALFUND | 261681 | 0.16% | 2025-02-28 |
| iShares Trust-iShares Genomics Immunology and Healthcare ETF | MUTUALFUND | 242039 | 0.15% | 2025-04-30 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | MUTUALFUND | 92156 | 0.06% | 2025-04-30 |
| SPDR INDEX SHARES FUNDS-SPDR(R) S&P(R) International Small Cap ETF | MUTUALFUND | 45659 | 0.03% | 2025-04-30 |
| ETFis Series Trust I-Virtus LifeSci Biotech Clinical Trials ETF | MUTUALFUND | 16294 | 0.01% | 2025-01-31 |
| Northern Funds-SMALL CAP CORE FUND | MUTUALFUND | 1007 | 0% | 2025-03-31 |